Kanabo Group’s Strong H1 Revenue Growth and Expansion

Kanabo Group (GB:KNB) has released an update.

Kanabo Group, an innovator in digital health and specialized medicines, reported a significant 55% revenue increase in the first half of 2024, driven by the expansion of their Treat-It clinic franchise and advancements in AI and e-prescription technologies. The company, which focuses on telehealth platforms and cannabis-based treatments, is poised for further growth with confidence in their strategic plan and upcoming product launches. Amidst these developments, Kanabo remains committed to enhancing patient access to healthcare and operational efficiency.

For further insights into GB:KNB stock, check out TipRanks’ Stock Analysis page.